Input string was not in a correct format. [LIVE] Coromandal Biotech Share Price | 52 Week High/Low Stocks | Stock History, Futures & Options Quote

Stock Price Quote

COROMANDAL BIOTECH INDUSTRIES INDIA LTD.

NSE : NABSE : 519293ISIN CODE : Industry : ChemicalsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-03 1992
Management Info
- Chairman Mallikarjuna Reddy Devireddy - Managing Director
Registered Office

Address Sy. No. 962,Kothakodur (V),T P Gudur (M),
Nellore Dist,
Andhra Pradesh-524101

Phone 0861-2328733

Email coromandalbio@gmail.com

Website  

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, Chennai

NEWS

No News Found

Financials

in Millions
QTR Jun 03 ANNUAL 00
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Jubilant Inds. (BSE)
peergroup  1363.25 (5.00%)
M.Cap ( in Cr)2054.02
Premier Explosives (BSE)
peergroup  1559.00 (2.53%)
M.Cap ( in Cr)1676.27
Tinna Rubber & Infra (BSE)
peergroup  719.50 (5.00%)
M.Cap ( in Cr)1232.47
Neogen Chemicals (BSE)
peergroup  1363.80 (2.07%)
M.Cap ( in Cr)3597.93
Solar Industries (BSE)
peergroup  6842.90 (0.35%)
M.Cap ( in Cr)61921.44

Shareholding Pattern

PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
NON-INSTITUTION 0%

About Coromandal Biotech Industries India Ltd.

Coromandal Biotech Industries India Ltd. was incorporated in the year 1992. Its today's share price is 0. Its current market capitalisation stands at Rs 0 Cr. In the latest

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.